Final GvHD Preclinical Report Confirms Treatment Benefit
Filed with ASX · · 2 pages · English
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Positive Preliminary Data from Preclinical HeartAttack Study
- Appendix 4C - quarterly
- Cynata Successfully Completes Capital Raising
- Cynata & FUJIFILM Sign Strategic Partnership Agreement
- Cynatas Clinical Study Approved in Austrralia
Later from Cynata Therapeutics
- CYP Advances Development of Cymerus for Treatment of Asthma
- Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation
- CYP in Collaboration on Acute Respiratory Distress Syndrome
- CYP Files for New Patent for Oncology Applications
- Cynata Advances to Pre-IND Meeting with US FDA
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics